口服PLGA包裹的CpG ODN和空肠弯曲菌裂解物可减少鸡盲肠内空肠弯曲菌定植
本研究评估可溶性与PLGA包裹的含未甲基化CpG基序的寡脱氧核苷酸(E-CpG ODN)及空肠弯曲菌裂解物作为多抗原疫苗对鸡空肠弯曲菌定植的保护效果。结果显示,口服低剂量(5微克)或高剂量(50微克)CpG使蛋鸡盲肠弯曲菌定植显著减少1.23和1.32 log10(P<0.05),E-CpG在感染后第22天使蛋鸡和肉鸡分别减少1.89和1.46 log10;裂解物使蛋鸡和肉鸡分别减少2.24和2.14 log10;E-CpG与裂解物联用使肉鸡盲肠内容物菌数减少2.42 log10。作者认为PLGA包裹的CpG或空肠弯曲菌裂解物可能是控制鸡空肠弯曲菌的有前景策略。
要点
- 口服5微克或50微克CpG使蛋鸡盲肠弯曲菌定植减少1.23和1.32 log10(P<0.05)。
- E-CpG使蛋鸡和肉鸡感染后第22天定植分别减少1.89和1.46 log10。
- 裂解物使蛋鸡和肉鸡定植分别减少2.24和2.14 log10,联用使肉鸡减少2.42 log10。
核心结论
- PLGA包裹的CpG或空肠弯曲菌裂解物可能是控制鸡空肠弯曲菌的有前景策略。
研究设计与样本
- 研究评估可溶性与PLGA包裹的CpG ODN及空肠弯曲菌裂解物作为多抗原疫苗对鸡空肠弯曲菌定植的保护效果。
主要发现
- 口服低剂量(5微克)或高剂量(50微克)CpG使蛋鸡盲肠弯曲菌定植分别减少1.23和1.32 log10(P<0.05)。
- E-CpG使蛋鸡和肉鸡感染后第22天盲肠弯曲菌定植分别减少1.89和1.46 log10。
- 口服空肠弯曲菌裂解物使蛋鸡和肉鸡感染后第22天肠道弯曲菌负荷分别减少2.24和2.14 log10。
- E-CpG与裂解物联用使肉鸡感染后第22天盲肠内容物菌数减少2.42 log10。
- 接受低或高剂量E-CpG或低剂量裂解物的肉鸡抗空肠弯曲菌IgG抗体滴度显著高于安慰剂组,且这些组血清IgG抗体滴度与盲肠弯曲菌计数呈正相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Campylobacter jejuni (C. jejuni) is a major cause of bacterial food-borne illness in humans. It is considered a commensal organism of the chicken gut and infected chickens serve as a reservoir and shed bacteria throughout their lifespan. Contaminated poultry products are considered the major source of infection in humans. Therefore, to reduce the risk of human campylobacteriosis, it is essential to reduce the bacterial load in poultry products. The present study aimed to evaluate the protective effects of soluble and PLGA-encapsulated oligodeoxynucleotides (ODN) containing unmethylated CpG motifs (E-CpG ODN) as well as C. jejuni lysate as a multi-antigen vaccine against colonization with C. jejuni. The results revealed that oral administration of a low (5 µg) or high (50 µg) dose of CpG resulted in a significant reduction in cecal C. jejuni colonization by 1.23 and 1.32 log10 (P < .05) in layer chickens, respectively, whereas E-CpG significantly reduced cecal C. jejuni colonization by 1.89 and 1.46 log10 in layer and broiler chickens at day 22 post-infection (slaughter age in broilers), respectively. Similar patterns were observed for C. jejuni lysate; oral administration of C. jejuni lysate reduced the intestinal burden of C. jejuni in layer and broiler chickens by 2.24 and 2.14 log10 at day 22 post-infection, respectively. Moreover, the combination of E-CpG and C. jejuni lysate reduced bacterial counts in cecal contents by 2.42 log10 at day 22 post-infection in broiler chickens. Anti-C. jejuni IgG antibody (Ab) titers were significantly higher for broiler chickens receiving a low or high dose of E-CpG or a low dose of C. jejuni lysate than for chickens receiving the placebo. Furthermore, a positive correlation was observed between serum IgG Ab titers and cecal counts of C. jejuni in these groups. These findings suggest that PLGA-encapsulated CpG or C. jejuni lysate could be a promising strategy for control of C. jejuni in chickens.
引用
- Taha-Abdelaziz K, Hodgins DC, Alkie TN, et al. Oral administration of PLGA-encapsulated CpG ODN and Campylobacter jejuni lysate reduces cecal colonization by Campylobacter jejuni in chickens. Vaccine. 2017. PMID: 29223488. doi:10.1016/j.vaccine.2017.11.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。